Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Yamanouchi reports VEGF inhibitors for angiogenesis-related disorders

July 21, 2004

First phase II monotherapy study of 17-AAG begins

July 21, 2004

Telomerase inhibitor inhibits glioblastoma growth in vivo

July 21, 2004

Tyropeptin A analogues with antitumor activity disclosed in patent

July 20, 2004

TGF-beta inhibitor claimed in Lilly patent

July 20, 2004

Aldara receives approval for superficial basal cell carcinoma

July 20, 2004

CancerVax licenses rights to SAI product candidates targeting EGFR

July 20, 2004

Small molecule VEGF antagonist inhibits tumor growth in vivo

July 20, 2004

Phosphotidylinositol 3-kinase inhibitors described by Chiron

July 19, 2004

Lilly claims TGF-beta signal transduction inhibitors

July 19, 2004

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...